Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Wierda

Showing results (61-70 of 181) with videos related to

Pageof 19
Sort By:
Cancer|April 25, 2003
Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaHagop Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Oncotarget|May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemiaDeqin Ma, Zhao Chen, Keyur P Patel, et al.
Oncotarget|September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Acta Haematologica|June 11, 2024
Effect of Digital Health Coaching on Self-Efficacy and Patient-Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled TrialJennifer Marvin-Peek, Valerie Shelton, Kelly Brassil, et al.
British Journal of Haematology|June 29, 2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapseFrancis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, et al.
Research Square|April 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progressionVarsha Gandhi, Shady Tantawy, Burcu Aslan, et al.
British Journal of Haematology|January 17, 2007
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemiaFrancis J Giles, Gautam Borthakur, Farhad Ravandi, et al.
Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.
Cancer|January 28, 2004
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapyGloria N Mattiuzzi, Hagop Kantarjian, Stefan Faderl, et al.
Pageof 19

Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
Cancer|April 25, 2003
Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaHagop Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
Oncotarget|May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemiaDeqin Ma, Zhao Chen, Keyur P Patel, et al.
Oncotarget|September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Acta Haematologica|June 11, 2024
Effect of Digital Health Coaching on Self-Efficacy and Patient-Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled TrialJennifer Marvin-Peek, Valerie Shelton, Kelly Brassil, et al.
British Journal of Haematology|June 29, 2006
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapseFrancis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, et al.
Research Square|April 16, 2025
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progressionVarsha Gandhi, Shady Tantawy, Burcu Aslan, et al.
British Journal of Haematology|January 17, 2007
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemiaFrancis J Giles, Gautam Borthakur, Farhad Ravandi, et al.
Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.
Cancer|January 28, 2004
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapyGloria N Mattiuzzi, Hagop Kantarjian, Stefan Faderl, et al.
Pageof 19